The company is scaling its precision vaginal microbiome platform to provide clinicians and patients with more detailed, clinically actionable insights into infections, fertility and menopausal health.

The company is scaling its precision vaginal microbiome platform to provide clinicians and patients with more detailed, clinically actionable insights into infections, fertility…

Juno Bio has raised $3.8 million from Ada Ventures, Artesian, Entrepreneur First, and Illumina Accelerator to scale precision vaginal microbiome testing.